Dr Lal Pathlabs - Dr. Lal Pathlabs Share Price

3,195.00-54.60 (-1.69%)
Volume: 68,499

Closed
Last Updated On: 08 Sep, 2025, 03:45 PM IST

3,195.00-54.60 (-1.69%)
Volume: 68,499

Stock Recommendations

Potential
Upside
1 Year
Target

HOLD

Mean Recos by
21 Analysts

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside

Stock Reports Plus

/10

Stock Score

View Report

Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum

No Rating (NR)

Negative

Neutral

Positive

Unlock Stock Score

Dr Lal Pathlabs share price insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.28% outperformed its 3 year CAGR of 6.02%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 19.6% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Dr Lal Pathlabs Share Price Update
Dr. Lal Pathlabs Ltd. share price moved down by -1.69% from its previous close of Rs 3,249.60. Dr. Lal Pathlabs Ltd. stock last traded price is 3,195.00
Share Price Value
Today/Current/Last 3,195.003,204.95
Previous Day 3,249.603,249.50

Share Price	Value
Today/Current/Last	3,195.003,204.95
Previous Day	3,249.603,249.50

InsightsDr Lal Pathlabs

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

52.17

EPS - TTM

(₹)

61.25

MCap

(₹ Cr.)

26,766.28

Sectoral MCap Rank

PB Ratio

(x)

12.34

Div Yield

(%)

0.75

Face Value

(₹)

10.00

Beta

1.34

VWAP

(₹)

3,201.17

52W H/L

(₹)

3,653.95 / 2,293.55

Dr Lal Pathlabs Share Price Returns

1 Day	-1.69%
1 Week	-2.36%
1 Month	0.15%
3 Months	12.25%
1 Year	-5.43%
3 Years	24.84%
5 Years	77.66%

ET Stock ScreenersTop Score Companies

Check whether Dr Lal Pathlabs belongs to analysts' top-rated companies list?

View Stock Screeners

Dr Lal Pathlabs News & Analysis

View all Dr Lal Pathlabs Share News & Announcements

Dr Lal Pathlabs Share Recommendations

Recent Recos

HOLD

Current

Mean Recos by 21 Analysts

Strong
SellSellHoldBuyStrong
Buy

Target₹2910
OrganizationHDFC Securities
ADD

Target₹3600
OrganizationJM Financial
BUY

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	3	3	3	2
Buy	11	11	11	11
Hold	2	2	2	3
Sell	3	3	3	3
Strong Sell	2	2	2	2
# Analysts	21	21	21	21

View all Stock Recommendations

Dr Lal Pathlabs Financials

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.28% outperformed its 3 year CAGR of 6.02%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 19.6% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	697.90	628.40	621.80	682.10	622.50
Total Income Growth (%)	11.06	1.06	-8.84	9.57	10.41
Total Expenses	512.10	470.00	478.20	493.00	466.60
Total Expenses Growth (%)	8.96	-1.71	-3.00	5.66	6.70
EBIT	185.80	158.40	143.60	189.10	155.90
EBIT Growth (%)	17.30	10.31	-24.06	21.30	23.24
Profit after Tax (PAT)	132.40	154.80	96.70	129.20	106.40
PAT Growth (%)	-14.47	60.08	-25.15	21.43	25.92
EBIT Margin (%)	26.62	25.21	23.09	27.72	25.04
Net Profit Margin (%)	18.97	24.63	15.55	18.94	17.09
Basic EPS (₹)	15.88	18.57	11.60	15.52	12.79

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	667.00	602.40	557.60	605.90	563.30
Total Income Growth (%)	10.72	8.03	-7.97	7.56	13.82
Total Expenses	490.10	452.70	401.60	417.60	396.80
Total Expenses Growth (%)	8.26	12.72	-3.83	5.24	7.68
EBIT	176.90	149.70	156.00	188.30	166.50
EBIT Growth (%)	18.17	-4.04	-17.15	13.09	31.72
Profit after Tax (PAT)	129.30	148.40	114.50	135.20	122.90
PAT Growth (%)	-12.87	29.61	-15.31	10.01	37.32
EBIT Margin (%)	26.52	24.85	27.98	31.08	29.56
Net Profit Margin (%)	19.39	24.63	20.53	22.31	21.82
Basic EPS (₹)	15.51	17.80	13.74	16.24	14.76

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2,554.83	2,295.81	2,058.60	2,139.95	1,632.60
Total Revenue Growth (%)	11.28	11.52	-3.80	31.08	17.84
Total Expenses	1,930.03	1,790.36	1,714.77	1,664.97	1,238.19
Total Expenses Growth (%)	7.80	4.41	2.99	34.47	15.19
Profit after Tax (PAT)	487.14	357.74	238.85	344.83	291.62
PAT Growth (%)	36.17	49.78	-30.74	18.25	29.09
Operating Profit Margin (%)	26.29	24.01	18.90	24.20	25.95
Net Profit Margin (%)	19.79	16.06	11.84	16.51	18.44
Basic EPS (₹)	58.48	43.05	28.82	41.70	35.33

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2,463.14	2,026.86	1,815.63	1,925.72	1,541.82
Total Revenue Growth (%)	21.52	11.63	-5.72	24.90	15.82
Total Expenses	1,841.86	1,510.89	1,424.80	1,466.33	1,167.78
Total Expenses Growth (%)	21.91	6.04	-2.83	25.57	13.54
Profit after Tax (PAT)	497.26	384.37	292.36	344.05	280.11
PAT Growth (%)	29.37	31.47	-15.03	22.83	25.50
Operating Profit Margin (%)	27.33	27.59	24.03	26.05	26.08
Net Profit Margin (%)	21.14	19.54	16.52	18.37	18.79
Basic EPS (₹)	59.70	46.25	35.28	41.61	33.93

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	2,716.79	2,455.96	2,385.56	2,353.22	1,661.33
Total Assets Growth (%)	10.62	2.95	1.37	41.65	20.88
Total Liabilities	510.31	570.60	686.02	809.55	385.20
Total Liabilities Growth (%)	-10.57	-16.82	-15.26	110.17	20.28
Total Equity	2,206.48	1,885.36	1,699.55	1,543.54	1,276.02
Total Equity Growth (%)	17.03	10.93	10.11	20.97	21.05
Current Ratio (x)	3.39	2.42	2.07	1.75	4.18
Total Debt to Equity (x)	0.00	0.05	0.14	0.23	0.00
Contingent Liabilities	21.37	20.29	18.28	25.99	20.10

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	2,620.95	2,415.44	2,320.17	2,213.92	1,573.08
Total Assets Growth (%)	8.51	4.11	4.80	40.74	19.35
Total Liabilities	486.72	515.78	630.31	737.45	355.99
Total Liabilities Growth (%)	-5.63	-18.17	-14.53	107.15	18.01
Total Equity	2,134.23	1,899.66	1,689.86	1,476.47	1,217.09
Total Equity Growth (%)	12.35	12.42	14.45	21.31	19.75
Current Ratio (x)	3.29	2.17	1.87	1.55	4.32
Total Debt to Equity (x)	0.00	0.04	0.14	0.23	0.00
Contingent Liabilities	21.33	20.23	18.01	25.99	19.18

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Increase in Cash from Investing
Company has used Rs 303.16 cr for investing activities which is an YoY increase of 1149.18%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	568.89	535.33	456.03	446.69	398.15
Net Cash used in Investing Activities	-303.16	-24.27	-287.31	-449.25	-212.02
Net Cash flow from Financing Activities	-334.03	-413.86	-283.18	136.45	-138.56
Net Cash Flow	-68.31	97.20	-114.46	133.90	47.58
Closing Cash & Cash Equivalent	292.63	360.93	263.73	378.20	244.30
Closing Cash & Cash Equivalent Growth (%)	-18.93	36.86	-30.27	54.81	24.20
Total Debt/ CFO (x)	0.00	0.16	0.52	0.77	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	540.00	477.60	427.53	423.81	373.36
Net Cash used in Investing Activities	-293.00	31.91	-288.47	-448.50	-195.19
Net Cash flow from Financing Activities	-324.75	-404.00	-270.05	142.04	-135.74
Net Cash Flow	-77.75	105.51	-130.99	117.34	42.42
Closing Cash & Cash Equivalent	266.60	325.83	220.32	349.01	231.67
Closing Cash & Cash Equivalent Growth (%)	-18.18	47.89	-36.87	50.65	22.38
Total Debt/ CFO (x)	0.00	0.17	0.55	0.82	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	22.42	19.34	14.33	22.86	23.42
Return on Capital Employed (%)	27.95	26.86	19.90	27.25	29.58
Return on Assets (%)	17.93	14.56	10.01	14.65	17.55
Interest Coverage Ratio (x)	35.37	23.11	14.16	20.32	25.65
Asset Turnover Ratio (x)	0.95	0.92	0.85	0.97	95.18
Price to Earnings (x)	42.55	52.91	64.10	63.29	77.52
Price to Book (x)	9.53	10.21	9.15	14.41	18.12
EV/EBITDA (x)	25.23	26.79	27.92	35.05	44.44
EBITDA Margin (%)	32.05	30.46	26.35	29.37	30.83

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	23.29	20.23	17.30	23.30	23.01
Return on Capital Employed (%)	28.79	27.26	22.52	27.65	29.44
Return on Assets (%)	18.97	15.91	12.60	15.54	17.80
Interest Coverage Ratio (x)	36.14	23.08	14.75	19.74	26.23
Asset Turnover Ratio (x)	0.93	0.83	0.78	0.99	94.75
Price to Earnings (x)	41.67	49.26	52.36	63.29	80.65
Price to Book (x)	9.71	9.94	9.02	14.72	18.54
EV/EBITDA (x)	25.67	29.53	29.45	38.23	47.26
EBITDA Margin (%)	33.03	31.49	28.67	30.07	30.77

Financial InsightsDr Lal Pathlabs

Income (P&L)
Cash Flow

- Beating 3 Yr Revenue CAGR
  Company's annual revenue growth of 11.28% outperformed its 3 year CAGR of 6.02%. (Source: Consolidated Financials)
- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 19.6% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
- Increase in Cash from Investing
  Company has used Rs 303.16 cr for investing activities which is an YoY increase of 1149.18%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Dr Lal Pathlabs Share Price Forecast

Get multiple analysts’ prediction on Dr Lal Pathlabs
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Dr Lal Pathlabs
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Dr Lal Pathlabs
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Dr Lal Pathlabs Technicals

Bullish / Bearish signals for Dr Lal Pathlabs basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 5 Sep 2025
5D EMA: 3288.26
Last 4 Sell Signals:22 Aug 2025
Date 7 days Gain/Loss %
22 Aug 2025 -2.96%
4 Aug 2025 0.03%
28 Jul 2025 -0.74%
14 Jul 2025 -0.75%
Average price decline of -2.64% within 7 days of Bearish signal in last 5 years
10 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 5 Sep 2025
10D EMA: 3299.27
Last 4 Sell Signals:26 Aug 2025
Date 7 days Gain/Loss %
26 Aug 2025 -3.28%
23 Jun 2025 -2.64%
18 Jun 2025 -1.58%
30 May 2025 -1.45%
Average price decline of -3.09% within 7 days of Bearish signal in last 5 years
14 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 5 Sep 2025
14D EMA: 3295.57
Last 4 Sell Signals:29 Aug 2025
Date 7 days Gain/Loss %
29 Aug 2025 -3.29%
23 Jun 2025 -2.64%
19 Jun 2025 -0.50%
30 May 2025 -1.45%
Average price decline of -2.96% within 7 days of Bearish signal in last 5 years
20 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 5 Sep 2025
20D EMA: 3276.86
Last 4 Sell Signals:1 Sep 2025
Date 7 days Gain/Loss %
1 Sep 2025 -2.20%
23 Jun 2025 -2.64%
19 Jun 2025 -0.50%
30 May 2025 -1.45%
Average price decline of -2.82% within 7 days of Bearish signal in last 5 years
Show More
44%
Positive Movement since
1st Jan 2005 on basis
55%
Negative Movement since
1st Jan 2005 on basis
Exclude
Global Meltdown - 1st Jan 2008 to 10th Nov 2008
Covid Crisis - 1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic 3239.63 3284.27 3363.67 3204.87 3160.23 3125.47 3046.07
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR 108.08 100.51 92.84

Date	7 days Gain/Loss %
22 Aug 2025	-2.96%
4 Aug 2025	0.03%
28 Jul 2025	-0.74%
14 Jul 2025	-0.75%

Date	7 days Gain/Loss %
26 Aug 2025	-3.28%
23 Jun 2025	-2.64%
18 Jun 2025	-1.58%
30 May 2025	-1.45%

Date	7 days Gain/Loss %
29 Aug 2025	-3.29%
23 Jun 2025	-2.64%
19 Jun 2025	-0.50%
30 May 2025	-1.45%

Date	7 days Gain/Loss %
1 Sep 2025	-2.20%
23 Jun 2025	-2.64%
19 Jun 2025	-0.50%
30 May 2025	-1.45%

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	3239.63	3284.27	3363.67	3204.87	3160.23	3125.47	3046.07

	5 DAYS	14 DAYS	28 DAYS
ATR	108.08	100.51	92.84

Dr Lal Pathlabs Peer Comparison

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Dr Lal Pathlabs Stock Performance	-1.69	-2.36	0.15	12.25	-5.43	24.84	77.66
Vijaya Diagnostic Stock Performance	-0.07	6.03	4.94	13.49	20.35	138.83	0.00
Metropolis Health Stock Performance	-2.42	0.19	7.18	30.29	0.62	45.29	20.37
Thyrocare Tech. Stock Performance	-0.38	2.46	-1.16	38.74	54.13	91.87	75.59
Krsnaa Diagnostics Stock Performance	-1.54	4.38	-2.35	22.67	10.53	62.99	0.00
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Dr Lal Pathlabs	52.17	12.13	22.42	27.95	17.93	6.02	26.29	19.99	58.48	3.39	0.00	0.00
Vijaya Diagnostic	75.71	14.22	17.98	19.88	11.23	13.62	32.42	21.10	13.16	1.89	0.00	0.00
Metropolis Health	73.32	8.36	10.89	13.31	7.76	2.59	15.73	10.93	28.29	1.18	0.01	0.05
Thyrocare Tech.	65.83	12.81	16.73	26.26	13.20	4.30	21.81	13.41	17.13	2.77	0.00	0.00
Krsnaa Diagnostics	33.51	3.04	8.79	13.04	6.05	16.27	17.75	10.82	24.04	1.36	0.19	1.90
Add More

Annual Ratios (%)

Choose from Peers

Choose from Stocks

See All Parameters

Peers InsightsDr Lal Pathlabs

Do you find these insights useful?

hate it
meh
love it

Dr Lal Pathlabs Shareholding Pattern

Loading...
Showing Dr Lal Pathlabs Shareholding as on Jun 2025
Category Jun 2025 Mar 2025 Dec 2024 Sep 2024
Promoters 53.79 53.91 53.91 53.92
Pledge 0.00 0.00 0.00 0.00
FII 21.68 23.90 26.82 26.82
DII 17.49 15.79 12.87 12.60
Mutual Funds 15.04 12.84 10.25 9.84
Others 7.04 6.40 6.40 6.65
Showing Shareholding as on Jun 2025
Category No. of Shares Percentage % Change QoQ
Promoters 4,50,61,135 53.79 % -0.11
Pledge 0 0.00 % 0.00
FII 1,81,64,456 21.68 % -2.21
DII 1,46,58,903 17.49 % 1.69
MF 1,26,01,898 15.04 % 2.19
Others 58,91,016 7.04 % 0.64

Category	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Promoters	53.79	53.91	53.91	53.92
Pledge	0.00	0.00	0.00	0.00
FII	21.68	23.90	26.82	26.82
DII	17.49	15.79	12.87	12.60
Mutual Funds	15.04	12.84	10.25	9.84
Others	7.04	6.40	6.40	6.65

Category	No. of Shares	Percentage	% Change QoQ
Promoters	4,50,61,135	53.79 %	-0.11
Pledge	0	0.00 %	0.00
FII	1,81,64,456	21.68 %	-2.21
DII	1,46,58,903	17.49 %	1.69
MF	1,26,01,898	15.04 %	2.19
Others	58,91,016	7.04 %	0.64

Dr Lal Pathlabs MF Ownership

HDFC Flexi Cap Direct-G
Equity: Flexi Cap
5
- 661.69
  Amount Invested (in Cr.)
- 0.82%
  % of AUM
- 0.00
  % Change (MoM basis)
UTI Flexi Cap Direct-G
Equity: Flexi Cap
1
- 414.19
  Amount Invested (in Cr.)
- 1.61256088%
  % of AUM
- 0.00
  % Change (MoM basis)
Aditya Birla SL Flexi Cap Direct-G
Equity: Flexi Cap
3
- 239.98
  Amount Invested (in Cr.)
- 1.03767341%
  % of AUM
- 23.20
  % Change (MoM basis)

MF Ownership as on 31 July 2025

View all Mutual Fund Schemes

Dr Lal Pathlabs F&O Quote

- ExpiryPlease select expiry month:
Price
-- (-%)
Open Interest
-- (-%)
Open High Low Prev Close Contracts Traded Turnover (₹ Lakhs)
- - - - - -
Open Interest as of

Open	High	Low	Prev Close	Contracts Traded	Turnover (₹ Lakhs)
-	-	-	-	-	-

Dr Lal Pathlabs Corporate Actions

Meeting Date	Announced on	Purpose	Details
Jul 31, 2025	Jul 24, 2025	Board Meeting	Quarterly Results, Dividend & Others
Jun 28, 2025	Apr 25, 2025	AGM	-
Apr 25, 2025	Apr 21, 2025	Board Meeting	Audited Results & Final Dividend
Mar 11, 2025	Feb 07, 2025	POM	-
Jan 30, 2025	Jan 23, 2025	Board Meeting	Quarterly Results, Dividend & Others

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Interim	60%	6.0	Aug 06, 2025	Jul 31, 2025
Final	60%	6.0	Jun 06, 2025	Apr 25, 2025
Interim	60%	6.0	Feb 05, 2025	Jan 30, 2025
Interim	60%	6.0	Nov 05, 2024	Oct 23, 2024
Interim	60%	6.0	Aug 20, 2024	Aug 07, 2024

No other corporate actions details are available.

About Dr Lal Pathlabs

Dr. Lal Pathlabs Ltd., incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 26,766.28 Crore) operating in Hospitals & Allied Services sector. Dr. Lal Pathlabs Ltd. key Products/Revenue Segments include Hospital Services and Other Operating Revenue for the year ending 31-Mar-2025. Show More

Executives
Auditors

AL
Arvind Lal
Executive Chairman
SB
Shankha Banerjee
Chief Executive Officer
VL
Vandana Lal
Whole Time Director
AL
Archana Lal Erdmann
Non Executive Director
RS
Rahul Sharma
Non Executive Director
AD
Arun Duggal
Independent Director
GS
Gurinder Singh Kalra
Independent Director
RM
Rajit Mehta
Independent Director
RB
Rohit Bhasin
Independent Director
SS
Somya Satsangi
Independent Director
VP
Ved Prakash Goel
Group Chief Financial Officer
VG
Vinay Gujral
Co. Secretary & Compl. Officer
Show More
Deloitte Haskins & Sells LLP

Industry

Diagnostics

Key Indices Listed on

Nifty Smallcap 100, Nifty 500, BSE 500, + 20 more

Address

Block E,Sector 18,New Delhi, Delhi - 110085

Contact

cs@lalpathlabs.com

https://www.lalpathlabs.com

More Details

FAQs about Dr Lal Pathlabs share

1. What's the Dr Lal Pathlabs share price today?
Dr Lal Pathlabs share price is Rs 3,195.00 as on 08 Sep, 2025, 03:54 PM IST. Dr Lal Pathlabs share price is down by 1.69% based on previous share price of Rs 3,319.4. Dr Lal Pathlabs share price trend:
- Last 3 Months: Dr Lal Pathlabs share price moved up by 12.25%
- Last 12 Months: Dr Lal Pathlabs share price moved down 5.43%
- Last 3 Years: Dr Lal Pathlabs Share price moved up by 24.84%
2. What is Dr Lal Pathlabs's 52 week high / low?
52 Week high of Dr Lal Pathlabs share is Rs 3,653.95 while 52 week low is Rs 2,293.55
3. What are the returns for Dr Lal Pathlabs share?
Return Performance of Dr Lal Pathlabs Shares:
- 1 Week: Dr Lal Pathlabs share price moved down by 2.36%
- 3 Month: Dr Lal Pathlabs share price moved up by 12.25%
- 6 Month: Dr Lal Pathlabs share price moved up by 28.15%
4. What's the market capitalization of Dr Lal Pathlabs?
Dr Lal Pathlabs share has a market capitalization of Rs 26,766.28 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 8.
5. What is the PE & PB ratio of Dr Lal Pathlabs?
The PE ratio of Dr Lal Pathlabs stands at 53.06, while the PB ratio is 12.31.

Trending in Markets

Top Gainers As on 03:59 PM | 08 Sep 2025

Suven Pharma 1,012.95

90.06 (9.76%)

Guj Mineral Dev.539.15

30.15 (5.93%)

Bharat Forge1,202.80

66.10 (5.82%)

Ashok Leyland137.29

6.52 (4.99%)

JP Power20.02

0.95 (4.99%)

Top Losers As on 03:57 PM | 08 Sep 2025

Amber Enterprises7,473.00

-320.50 (-4.12%)

EID Parry1,067.30

-45.50 (-4.09%)

Trent5,315.50

-213.00 (-3.86%)

Godfrey Philips10,657.00

-416.00 (-3.76%)

Coromandel Int.2,185.20

-72.71 (-3.22%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

1 Day	-1.37%
1 Week	-2.03%
1 Month	0.49%
3 Months	12.48%
1 Year	-5.17%
3 Years	25.29%
5 Years	78.34%

ETPrime

Dr Lal Pathlabs - Dr. Lal Pathlabs Share Price

Dr Lal Pathlabs share price insights

InsightsDr Lal Pathlabs

Key Metrics

Key Metrics

Dr Lal Pathlabs Share Price Returns

ET Stock ScreenersTop Score Companies

Dr Lal Pathlabs News & Analysis

Dr Lal Pathlabs Share Recommendations

Recent Recos

Analyst Trends

Dr Lal Pathlabs Financials

Insights

Insights

Financial InsightsDr Lal Pathlabs

Dr Lal Pathlabs Share Price Forecast

Get multiple analysts’ prediction on Dr Lal Pathlabs

Get multiple analysts’ prediction on Dr Lal Pathlabs

Get multiple analysts’ prediction on Dr Lal Pathlabs

Dr Lal Pathlabs Technicals

Pivot Levels

Average True Range

Dr Lal Pathlabs Peer Comparison

Ratio Performance

Peers InsightsDr Lal Pathlabs

Dr Lal Pathlabs Shareholding Pattern

Dr Lal Pathlabs MF Ownership

HDFC Flexi Cap Direct-G

UTI Flexi Cap Direct-G

Aditya Birla SL Flexi Cap Direct-G

Dr Lal Pathlabs F&O Quote

Dr Lal Pathlabs Corporate Actions

About Dr Lal Pathlabs

Executives

Auditors

More Details

FAQs about Dr Lal Pathlabs share

Trending in Markets

Top Gainers As on 03:59 PM | 08 Sep 2025

Top Losers As on 03:57 PM | 08 Sep 2025

Dr Lal Pathlabs Quick Links

Equity Quick Links

More from Markets